Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. Preclinical protein degradation biotech Kymera Therapeutics (KYMR) upsized and priced above the range to raise $174 million at a $938...read more
Nano-X Imaging, which is developing affordable medical imaging systems, raised $165 million by offering 9.2 million shares at $18, the high end of the range of $16 to $18. The company offered 0.4 million more shares than anticipated. It originally planned to...read more
Nano-X Imaging, which is developing affordable medical imaging systems, raised the proposed deal size for its upcoming IPO on Thursday. The Neve Ilan, Israel-based company now plans to raise $150 million by offering 8.8 million shares at a price range of...read more
Updated Monday, 8/17.
Three biotechs, a medical imaging company, and three SPACs are scheduled to go public in the week ahead. While the annual summer slowdown is setting in, the IPO market is still in the midst of its most active August since...read more
US IPO Weekly Recap: Biotechs and SPACs ride the summer wave in a 4 IPO week
Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. Preclinical protein degradation biotech Kymera Therapeutics (KYMR) upsized and priced above the range to raise $174 million at a $938...read more
Israeli medical imaging company Nano-X Imaging prices further upsized US IPO at $18 high end
Nano-X Imaging, which is developing affordable medical imaging systems, raised $165 million by offering 9.2 million shares at $18, the high end of the range of $16 to $18. The company offered 0.4 million more shares than anticipated. It originally planned to...read more
Israeli medical imaging company Nano-X Imaging ups proposed share offering by 50% ahead of $150 million US IPO
Nano-X Imaging, which is developing affordable medical imaging systems, raised the proposed deal size for its upcoming IPO on Thursday. The Neve Ilan, Israel-based company now plans to raise $150 million by offering 8.8 million shares at a price range of...read more
US IPO Week Ahead: The IPO market's summer slowdown approaches in a 4 IPO week
Updated Monday, 8/17. Three biotechs, a medical imaging company, and three SPACs are scheduled to go public in the week ahead. While the annual summer slowdown is setting in, the IPO market is still in the midst of its most active August since...read more